Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Evenamide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Newron presents H1 2024 results and provides business update
    Newron presents H1 2024 results and provides business update

    19 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240919982611/en

    BUSINESSWIRE
    19 Sep 2024
    Share Share
    Newron schizophrenia add-on improves positive, negative symptoms
    Newron schizophrenia add-on improves positive, negative symptoms

    30 Apr 2024

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/ai-and-machine-learning/newrons-schizophrenia-add-improves-symptoms-charging-case-phase-3-test

    Annalee Armstrong FIERCE BIOTECH
    30 Apr 2024
    Share Share
    Data from Newron’s Study and An Evenamide Clinical Outlook Presented at The SIRS
    Data from Newron’s Study and An Evenamide Clinical Outlook Presented at The SIRS

    08 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240408718700/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share
    Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide
    Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104787993/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Newron Completes Enrollment of Schizophrenia Patients in Study 008A
    Newron Completes Enrollment of Schizophrenia Patients in Study 008A

    29 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231229998281/en

    BUSINESSWIRE
    29 Dec 2023
    Share Share
    Newron to Present Three Posters on Its Clinical Program Evaluating Evenamide
    Newron to Present Three Posters on Its Clinical Program Evaluating Evenamide

    04 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231004618103/en

    BUSINESSWIRE
    04 Oct 2023
    Share Share